Vanguard Group Inc Cogent Biosciences, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 5,714,405 shares of COGT stock, worth $51.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,714,405

Previous 5,259,879 8.64%

Holding current value

$51.3 Million

Previous $44.3 Million 39.19%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$8.24 - $11.48 $3.75 Million - $5.22 Million	454,526 Added 8.64%	5,714,405 $61.7 Million
Q2 2024 Aug 13, 2024	SELL	$6.01 - $9.04 $3.04 Million - $4.57 Million	-505,826 Reduced 8.77%	5,259,879 $44.3 Million
Q1 2024 May 10, 2024	BUY	$4.38 - $9.02 $5.39 Million - $11.1 Million	1,231,050 Added 27.15%	5,765,705 $38.7 Million
Q4 2023 Feb 14, 2024	BUY	$4.06 - $10.08 $655,056 - $1.63 Million	161,344 Added 3.69%	4,534,655 $26.7 Million
Q3 2023 Nov 14, 2023	SELL	$9.69 - $13.34 $613,473 - $844,555	-63,310 Reduced 1.43%	4,373,311 $42.6 Million
Q2 2023 Aug 14, 2023	BUY	$9.85 - $13.24 $8.87 Million - $11.9 Million	900,362 Added 25.46%	4,436,621 $52.5 Million
Q1 2023 May 15, 2023	BUY	$10.04 - $15.5 $707,488 - $1.09 Million	70,467 Added 2.03%	3,536,259 $38.2 Million
Q4 2022 Feb 10, 2023	BUY	$10.65 - $14.84 $3 Million - $4.19 Million	282,022 Added 8.86%	3,465,792 $40.1 Million
Q3 2022 Nov 14, 2022	BUY	$9.39 - $16.99 $5.61 Million - $10.2 Million	597,966 Added 23.12%	3,183,770 $47.5 Million
Q2 2022 Aug 12, 2022	BUY	$3.92 - $9.73 $3.7 Million - $9.17 Million	942,835 Added 57.39%	2,585,804 $23.3 Million
Q1 2022 May 13, 2022	SELL	$5.31 - $8.7 $51,846 - $84,946	-9,764 Reduced 0.59%	1,642,969 $12.3 Million
Q4 2021 Feb 14, 2022	BUY	$7.51 - $10.81 $417,683 - $601,219	55,617 Added 3.48%	1,652,733 $14.2 Million
Q3 2021 Nov 12, 2021	SELL	$5.99 - $9.14 $57,941 - $88,411	-9,673 Reduced 0.6%	1,597,116 $13.4 Million
Q2 2021 Aug 13, 2021	BUY	$7.82 - $9.3 $12.6 Million - $14.9 Million	1,606,789 New	1,606,789 $13 Million

Others Institutions Holding COGT

# of Institutions

171

Shares Held

113M

Call Options Held

56.7K

Put Options Held

40.4K

View Full List

About Cogent Biosciences, Inc.

Ticker COGT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,758,300
Market Cap $591M
Description
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...

More about COGT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Cogent Biosciences, Inc. Transaction History